Trial Profile
A Multi-center, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of StaccatoTM Prochlorperazine for Inhalation in Patients With Migraine Headache
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jan 2018
Price :
$35
*
At a glance
- Drugs Prochlorperazine (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Alexza Pharmaceuticals
- 13 Mar 2008 New trial record.